At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ODD ODDITY Tech Ltd.
Closed Good Friday 04-17 16:00:00 EDT
41.95
+1.50
+3.70%
盘后41.00
-0.95-2.26%
16:55 EDT
| High42.12 | Low40.65 | Vol310.71K |
| Open41.62 | D1 Closing40.46 | Amplitude3.63% |
| Mkt Cap2.34B | Tradable Cap1.39B | Total Shares55.83M |
| T/O12.95M | T/O Rate0.94% | Tradable Shares33.22M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
ODDITY Tech Is Maintained at Overweight by Keybanc
Dow Jones · 04-16 12:55
Avidity Biosciences Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
PR Newswire · 04-08
Cboe Global Markets Reports Trading Volume for March 2025
PR Newswire · 04-03
Oddity Tech (NasdaqGM:ODD) Surges 13% Last Quarter Following Strong Earnings with Sales Hitting US$124M
Simply Wall St. · 04-03
Oddity Tech (NasdaqGM:ODD) Surges 13% Last Quarter Following Strong Earnings with Sales Hitting US$124M
Cadrenal Therapeutics Participates in Key Medical and Business Development Conferences
Business Wire · 04-03
3 Stocks That May Be Trading Up To 36.1% Below Their Intrinsic Value Estimates
Simply Wall St. · 04-03
CVKD: Preparing for Phase 3 Trial of Tecarfarin…
Zacks Small Cap Research · 03-31
Press Release: INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
Dow Jones · 03-27
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly
GlobeNewswire · 03-27
Shandong Boan Biotechnology Cancer Drug Granted U.S. FDA Orphan Drug Designation
MT Newswires Live · 03-27
Press Release: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
Dow Jones · 03-20
BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
ACCESS Newswire · 03-20
Press Release: Jacobio Pharma Announces 2024 Annual Results
Dow Jones · 03-19
3 High Growth Companies With Strong Insider Ownership
Simply Wall St. · 03-18
BioArctic receives Orphan Drug Designation for exidavnemab the US
PR Newswire · 03-17
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
GlobeNewswire · 03-17
Is Oddity Tech Ltd.'s (NASDAQ:ODD) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. · 03-15
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
GlobeNewswire · 03-13
Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin
Dow Jones · 03-13
Oddity Tech (ODD) Just Overtook the 20-Day Moving Average
Zacks · 03-13
Introduction
Company Name.
ODDITY Tech Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Oddity Tech Ltd. operates as a consumer tech company that builds and scales digital-first brands to disrupt beauty and wellness industries. The company serves consumers worldwide through its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. It owns IL MAKIAGE and SpoiledChild brands. The company was incorporated in 2013 and is headquartered in Tel Aviv, Israel with additional office in New York, New York.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App